Janus Henderson Investors US’s Clovis Oncology, Inc. CLVS Stock Holding History

Janus Henderson Investors US’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-317,359	Closed	-$29.2M	–	1242
2015 Q3	$29.2M	Sell	317,359 -13,570	-4%	-$1.17M	0.03%	527
2015 Q2	$29.1M	Buy	330,929 +2,676	+0.8%	+$229K	0.02%	543
2015 Q1	$24.4M	Sell	328,253 -175,870	-35%	-$12.4M	0.02%	581
2014 Q4	$28.2M	Buy	+504,123	New	+$26.5M	0.02%	547
2014 Q3	–	Sell	-268,977	Closed	-$11.1M	–	1135
2014 Q2	$11.1M	Buy	268,977 +17,188	+7%	+$885K	0.01%	654
2014 Q1	$17.4M	Buy	251,789 +71,260	+39%	+$5.23M	0.02%	577
2013 Q4	$10.9M	Buy	180,529 +22,464	+14%	+$1.22M	0.01%	652
2013 Q3	$9.61M	Buy	158,065 +41,880	+36%	+$2.97M	0.01%	651
2013 Q2	$7.78M	Buy	+116,185	New	+$5.22M	0.01%	651

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Investors US's CLVS Position: Q4 2015 in Review

Janus Henderson Investors US sold out of Clovis Oncology, Inc. (CLVS) in Q4 2015, closing a stake of 317,359 shares — an estimated $29.2M sold.

Janus Henderson Investors US first reported a position in CLVS in Q2 2013 and held it in 9 quarters. The position peaked at $29.2M in Q3 2015. 157 funds tracked by Wall St. Rank hold CLVS as of Q4 2015.

Janus Henderson Investors US reported no remaining Clovis Oncology, Inc. position as of Q4 2015 after selling out during the quarter.
Janus Henderson Investors US sold 317,359 Clovis Oncology, Inc. shares in Q4 2015, an estimated $29.2M.
Janus Henderson Investors US first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 9 quarters.
Janus Henderson Investors US's Clovis Oncology, Inc. position peaked at $29.2M in Q3 2015.
157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2015.

Based on Janus Henderson Investors US's 13F filing for Q4 2015, filed 16 Feb 2016.